Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
l. Loued (Tunis, Tunisia), S. Toujani (Tunis, Tunisia), A. Hedhli (Tunis, Tunisia), S. Cheikhrouhou (Tunis, Tunisia), Y. Ouahchi (Tunis, Tunisia), M. Mjid (Tunis, Tunisia), S. Meraii (Tunis, Tunisia). Psychological impact of diffuse infiltrative lung disease. 3015

Member's Comments

No comment yet.

Related content which might interest you: Update on diffuse parenchymal lung disease Source: Eur Respir Rev 2009; 19: 97-108 Year: 2010 Drug-induced infiltrative lung disease Source: Eur Respir Mon; 2009: 46: 287–318 Year: 2009 Diffuse parenchymal lung disease Source: Eur Respir Rev, 26 (144) 170004; 10.1183/16000617.0004-2017 Year: 2017 Diffuse parenchymal lung disease Source: International Congress 2016 – Clinical year in review Year: 2016 Diffuse parenchymal lung disease: a different perspective Source: ISSN=ISSN 1810-6838, ISBN=, page=240 Year: 2008 The benefit of surgical lung biopsy in diagnosis and prognosis of diffuse infiltrative lung disease Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery Year: 2007 Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Alveoscopy in diffuse interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 244s Year: 2007 Clinical course and outcome of vasculitis related interstitial lung disease Source: International Congress 2014 – ILDs 2 Year: 2014 Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Radiology in diffuse parenchymal lung disease and lung nodules Source: Eur Respir Rev, 26 (144) 170049; 10.1183/16000617.0049-2017 Year: 2017 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020 Year: 2020 Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020 Year: 2020 Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 5 Year: 2014 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 6 Year: 2014 Depiction of malignancy in patients with diffuse interstitial lung disease (DILD) presenting with nodular opacities Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018